<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00042497</url>
  </required_header>
  <id_info>
    <org_study_id>AN2002-04</org_study_id>
    <nct_id>NCT00042497</nct_id>
  </id_info>
  <brief_title>Immunotherapy With Autologous Dexosomes for Patients With Stage IV Melanoma</brief_title>
  <official_title>A Phase II, Multicenter, Open-Labeled Study of Immunotherapy With Autologous Dexosomes for Patients With Stage IV Melanoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Anosys</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Anosys</source>
  <brief_summary>
    <textblock>
      The objective is to determine the safety and efficacy of dexosome immunotherapy in patients
      with Stage IV malignant melanoma
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <start_date>July 2002</start_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <enrollment>60</enrollment>
  <condition>Melanoma</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>autologous dexosomes loaded with tumor-specific peptides</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        -  Patients with Stage IV metastatic melanoma with 0-1 prior treatments for metastatic
             disease.

          -  All patients must have distant skin, subcutaneous, or nodal metastases (M1a) or lung
             metastases (M1b), measurable disease, normal lactate dehydrogenase levels, and HLA
             type A1, A2, or B35.

          -  Patients must have adequate organ function and an estimated life expectancy of at
             least 3 months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>September 2002</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 30, 2002</study_first_submitted>
  <study_first_submitted_qc>July 31, 2002</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 1, 2002</study_first_posted>
  <last_update_submitted>June 23, 2005</last_update_submitted>
  <last_update_submitted_qc>June 23, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 24, 2005</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melanoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

